Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.77
+0.11000.07%
Post-market: 167.70-0.0700-0.04%19:59 EDT
Volume:7.16M
Turnover:1.20B
Market Cap:43.56B
PE:-11.80
High:168.80
Open:167.75
Low:167.41
Close:167.66
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.91
T/O Rate:2.76%
Dividend:2.53
Dividend Rate:1.51%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.27
PE(LYR):-11.80

Loading ...

Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)

TIPRANKS
·
Sep 15

Eton Pharmaceuticals participates in a conference call with Craig-Hallum

TIPRANKS
·
Sep 15

UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says

MT Newswires Live
·
Sep 14

Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Zentek (OtherZTEKF)

TIPRANKS
·
Sep 14

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)

TIPRANKS
·
Sep 14

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

GE Healthcare Kept at Hold as Analyst Weighs Sofie Deal Upside Against Execution Risks; $71 Price Target Reiterated

TIPRANKS
·
Sep 14

Eli Lilly Announces R$ 0.2 Per Unit Dividend for 3Q 2026 BDRs

Reuters
·
Sep 14

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback

MT Newswires Live
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

Evercore ISI Remains a Buy on UnitedHealth (UNH)

TIPRANKS
·
Sep 14

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

Reuters
·
Sep 14

J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc

THOMSON REUTERS
·
Sep 14

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS
·
Sep 14

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS
·
Sep 14

BofA Adjusts Price Target on HCA Healthcare to $450 From $425

MT Newswires Live
·
Sep 14

BofA Adjusts Price Target on AMN Healthcare Services to $28 From $26

MT Newswires Live
·
Sep 14

BofA Adjusts Price Target on Acadia Healthcare to $17 From $14.50

MT Newswires Live
·
Sep 14

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Sep 14

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Sep 14